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Abstract
Background: Expanded polytetrafluoroethylene (ePTFE) vascular grafts frequently
develop occlusive neointimal hyperplasia as a result of myofibroblast over-growth,
leading to graft failure. ePTFE exhibits higher ultrasound attenuation than native soft
tissues. We modelled the selective absorption of ultrasound by ePTFE, and explored
the feasibility of preventing hyperplasia in ePTFE grafts by ultrasound heating.
Specifically, we simulated the temperature profiles of implanted grafts and nearby
soft tissues and blood under ultrasound exposure. The goal was to determine
whether ultrasound exposure of an ePTFE graft can generate temperatures sufficient
to prevent cell growth on the graft without damaging nearby soft tissues and blood.
Methods: Ultrasound beams from two transducers (1.5 and 3.2 MHz) were simulated
in two graft/tissue models, with and without an intra-graft cellular layer mimicking
hyperplasia, using the finite-difference time-domain (FDTD) method. The resulting
power deposition patterns were used as a heat source for the Pennes bioheat
equation in a COMSOL
® Multiphysics heat transfer model. 50°C is known to cause
cell death and therefore the transducer powers were adjusted to produce a 13°C
temperature rise from 37°C in the ePTFE.
Results: Simulations showed that both the frequency of the transducers and the
presence of hyperplasia significantly affect the power deposition patterns and
subsequent temperature profiles on the grafts and nearby tissues. While neither
transducer significantly raised the temperature of the blood, the 1.5-MHz transducer
was less focused and heated larger volumes of the graft and nearby soft tissues than
the 3.2-MHz transducer. The presence of hyperplasia had little effect on the blood’s
temperature, but further increased the temperature of the graft and nearby soft
tissues in response to either transducer. Skin cooling and blood flow play a
significant role in preventing overheating of the native tissues.
Conclusions: Modelling shows that ultrasound can selectively heat ePTFE grafts and
produce temperatures that cause cell death on the graft. The temperature increase
in blood is negligible and that in the adjacent soft tissues may be minimized by skin
cooling and using appropriate transducers. Therefore, ultrasound heating may have
the potential to reduce neointimal hyperplasia and failure of ePTFE vascular grafts.
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There are two primary types of permanent hemodialysis accesses, native arteriovenous
(AV) fistulae and expanded-polytetrafluoroethylene (ePTFE) AV grafts. When com-
pared to the fistula, AV grafts provide vascular access with higher blood flow rates, do
not require a maturation period, and can be used sooner after surgical placement.
Grafts are a particularly useful form of vascular access in patients whose vasculature is
insufficient to support a functional native AV fistula. The latter is important because
up to 60% of AV fistulae in the United States fail to mature and become functional.
Despite these advantages, only 23.3% of the permanent hemodialysis vascular accesses
in the United States are AV grafts [1], largely due to their low one- and two-year
primary patency rates, being 50% and 25%, respectively [2,3].
The low primary patency rates of ePTFE grafts are attributed to their propensity to
develop excessive cell growth in the graft lumen, preferentially near the graft-venous
anastomosis site [4]. This growth, termed neointimal hyperplasia (NH), causes lumen
stenosis that predisposes to thrombosis and occlusion. If the occurrence of NH could
be prevented or reduced, the synthetic graft should be an excellent form of dialysis
vascular access for the large population of dialysis patients whose vasculature cannot
support a functional AV fistula.
Strategies to prevent or reduce NH in synthetic AV grafts include the use of drug-elut-
ing stents [5,6], endothelialization of the graft lumen [7-9], antiproliferative drugs deliv-
ered using hydrogel systems to prevent cell overgrowth [5,6,10-12], and catheter-based
gamma radiation [13]. The stent and catheter treatments require invasive procedures,
and none of the strategies has proven effective in humans.
Ultrasound has been used for a variety of therapeutic applications including muscle
diathermy and bone healing [14], drug delivery [15] and mild hyperthermia [16-18].
Ultrasound exposure has been shown to reduce smooth muscle cell proliferation in vitro
[19]. Intravascular ultrasound has also been shown to reduce NH in implanted stents by
35% [20]. Ultrasound is comprised of acoustic or vibrational waves that carry mechanical
energy. The amount of acoustic energy that is deposited in a material and converted into
heat is approximately proportional to the material’s viscosity [21]. Since ePTFE exhibits
5 to 10 times more ultrasound attenuation (absorption and scattering) than native soft
tissues, transcutaneous delivery of ultrasound may provide a noninvasive method to
selectively heat an implanted ePTFE graft, thereby preventing cell growth and NH on
the graft surface [22,23].
In this study, we modelled the selective absorption of ultrasound in ePTFE and the cor-
responding thermal profiles to determine whether ultrasound exposure can elevate the
graft to temperatures capable of inflicting NH cell death without significantly damaging the
nearby tissues and blood. Specifically, we used mathematical and computational modelling
to simulate the ultrasound power absorbed and the effectual temperature profiles in
implanted grafts and nearby tissues and blood under ultrasound generated from two
different transducers.
Methods
Overview
The modelling involved two steps. In the first step, the power deposited throughout a
simplified ePTFE graft/tissue model was calculated using a three-dimensional (3D)
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FDTD method is its ability to handle heterogeneous models readily. The power deposi-
tion values, serving as the heat source, were next used to generate 3D temperature
profiles using COMSOL
® Multiphysics software and the Pennes bioheat equation [28].
Two transducers with different frequencies, focal lengths and diameters (Table 1) were
used to generate power deposition patterns. Since 50°C is known to cause cell death
[29], the transducer powers were adjusted to produce a 13°C temperature increase
from 37°C in the ePTFE. The temperatures after 5-second or 30-second ultrasound
exposures, as well as during the cooling period back to 37°C, were also modelled.
FDTD Simulations
To obtain a 3D pattern of the ultrasound power density deposited in the graft/tissue
models, we applied the FDTD numerical technique to equations that describe the pro-
pagation of an acoustic pressure wave through a medium. The 3D models have a form
composed of individual regularly spaced cuboidal voxels, each with possibly different
densities, speeds of sound and attenuation properties, and with planar front faces.
Acoustic waves can be described using Newton’s force equation and the conservation
of mass. Using finite differences these equations can be solved for the acoustic pressure
and the particle velocity in the x, y and z directions. The method of finite differences
involves replacing classical derivatives with discrete differences in time and on a 3D
grid space. For example, the derivative of the x-direction particle velocity with respect
to x becomes the difference of the particle velocity at locations x and x+Δx divided
by Δx, the FDTD grid resolution in the x direction (see details in Appendix A). Using
initial pressure values, the particle velocities in the x, y and z directions for the entire
grid and the first time step are calculated. Then, using the newly calculated particle
velocities, new pressure values for the same time step are calculated. Continuing in
this manner the program, written in MATLAB, works by iterating back and forth
between space and time steps solving for the particle velocities and pressure as the
acoustic wave propagates through the 3D gridded models of the inhomogeneous
medium.
Since the two transducers that were modelled had spherically curved emitting sur-
faces as described in Table 1 we needed to first propagate the pressure waves in the
water region between the curved transducer surfaces and the front plane of the model
(corresponding to the skin surface). This stand-off distance was 15.66 cm and 1.16 cm
for the 1.5-MHz and 3.2-MHz transducers, respectively. Instead of employing the
FDTD method for this step, we used the Rayleigh-Sommerfeld integral approach [30]
(appropriate for a homogeneous medium such as water) to find the pressure pattern
on the front model plane, which then became the incident pressure pattern for the
FDTD calculations. Four simplified ePTFE g r a f t / t i s s u em o d e l s( s e eF i g u r e1 )w i t h
Table 1 Transducer parameters
Transducer 1 Transducer 2
Frequency 1.5 MHz 3.2 MHz
Focal length 18 cm 3.5 cm
Diameter 10 cm 2.5 cm
Acoustic power 0.6 W 0.375 W
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the two transducers analyzed. No special FDTD boundary conditions were found to be
necessary; the FDTD pressure solution was terminated before the beam reflected off
the back wall of the large grid. Reflections from the four side walls of the model were
insignificant because the beam cross-section was shrinking due to focusing.
The accuracy of the FDTD method depends on the chosen temporal and spatial step
size. While smaller step sizes more closely approximate the original differential equa-
tions and tissue geometry, small step sizes result in large models and long calculation
times. FDTD simulations were completed on a computer using an Intel
® Core™ i7
processor at 2.67 GHz and with 11.9 GB RAM. To avoid aliasing, the model grid spa-
cings Δx, Δy and Δz were set to 0.1 mm for the 1.5-MHz models and to 0.05 mm for
the 3.2-MHz models, roughly 1/10
th of the acoustic wavelength in water for the respec-
tive frequencies. The overall dimensions of the 1.5-MHz models were 2 × 2 × 4 cm,
producing a model with 200 × 200 × 400 elements. Because the 0.05-mm step size in
the 3.2-MHz models would produce eight times as many elements as the 1.5-MHz
models (exceeding the memory limits of the computer), the overall dimensions of the
3.2-MHz model were reduced to 1.5 × 1.5 × 3 cm, resulting in 300 × 300 × 600 ele-
ments. Some clipping of the incident power occurred since the areas of the front
planes of the models (1.5 × 1.5 cm and 2 × 2 cm) were slightly smaller than the extent
of the beams from the transducer. This clipping caused 2.5% and 7.5% reductions in
the power from the 1.5- and 3.2-MHz transducers, respectively.
Physiological models for acoustic simulation
Physiological acoustic properties (Table 2) [31,32] were used in the FDTD calculations.
Two scenarios were modeled for each transducer: grafts free of NH and grafts with
1.2-mm thick hyperplasia. Even though NH most commonly occurs at the graft-vein
anastomosis, for simplicity the model did not include the anastamosis and modeled
Figure 1 Slice views of the 1.5-MHz and 3.2-MHz transducer models with and without hyperplasia.
Slice views transverse to the graft at the center of the 1.5-MHz transducer model (a) without hyperplasia
and (b) with hyperplasia; (c) and (d) show the same slices for the 3.2-MHz transducer model. The scale is
not the same for each model; the 1.5-MHz model dimensions are 2 × 2 × 4 cm, while the 3.2-MHz model
is 1.5 × 1.5 × 3 cm. In both models the graft is cylindrical with a 0.6-cm inner diameter and a 0.6-mm wall
thickness. The skin surface is located at the left boundary of each figure.
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sound power deposition and heating in the graft, as well as conductive and convective
heat transfer.
Using the FDTD algorithm, the acoustic pressure wave was calculated as it moved
through the x, y and z grid space. The absorbed power density Q, in W/m
3, is the time
average (within each cycle) of power deposited per unit volume throughout the 3D
model. It depends on the acoustic pressure and the material through which the wave is
travelling as follows [21]:
Q =
α | p2 |
ρc

1+(α · c)2

2π · f
2
, (1)
where a is material pressure attenuation coefficient, r is material mass density, c is
speed of sound, p is the rms pressure and f is the frequency of the wave. During the
duration of the ultrasound exposure, the magnitude of the applied acoustic power and
pressure was held constant. After calculating Q from the 3D FDTD pressure solution,
it was used as a heat source in the Pennes bioheat equation.
Heat transfer using COMSOL Multiphysics
The general 3D heat transfer application in COMSOL Multiphysics, a commercial
finite-element method (FEM) modelling software designed to solve heat transfer,
acoustic, fluid flow and other engineering problems described by differential equations,
was used. The simplified graft/tissue models used for the FDTD calculations were also
used in COMSOL. The thermal properties assumed for the blood, ePTFE, muscle and
fat regions are listed in Table 2.
To simulate skin cooling, the front fat boundary was held constant at 20°C. Except
where the blood entered the graft/tissue model (where the entering blood temperature
was held constant at body temperature of 37°C), all other exterior boundary conditions
were considered insulated, allowing no heat flux across exterior boundaries. Insulated
boundaries provide an accurate assumption if the simulated volume is large enough
that the side and rear boundaries are much farther from the ultrasound heated region
than the nominal diffusion length.
Physiologically relevant blood flow volumes and velocities were included in the mod-
elling, and the COMSOL Multiphysics software has the capability to model flow within
the heat transfer application. In implanted grafts, blood flow near the anastomosis is
often turbulent, and may contribute to neointimal proliferation [33]. However, for sim-
plicity, convection in the graft lumen was modelled using laminar blood flow.
Table 2 Material properties used for acoustic FDTD and COMSOL thermal modelling
Blood Muscle Fat ePTFE
Density (r) [kg/m
3] 1060
b 1070
b 937
b 1230
c
Specific heat capacity (Cp) [J/kg·K] 3894
a 3140
a 2600
a 1172
d
Thermal conductivity (k) [W/m·K] 0.5
a 0.5
a 0.7
a 0.35
d
Perfusion (ω)[ s
-1] NA 6.776e-4
a 4.373e-4
a NA
Speed of sound (c) [m/s] 1580
b 1579
b 1426
b 1237
c
Attenuation (a) at 1.5/3.2 MHz [Np/m] 4.5/9.6
b 13.5/29.7
b 10.5/22.4
b 116/247.6
c
Obtained from
aDuck [31],
bChristensen [21],
cVickers [23] and
dIncropera [32].
Brinton et al. Theoretical Biology and Medical Modelling 2011, 8:42
http://www.tbiomed.com/content/8/1/42
Page 5 of 15Volumetric flow rates based on clinical data were used to determine the peak and
mean velocities for the laminar velocity distribution. For the graft without NH, given a
luminal cross-sectional area of 28.3 mm
2, an average flow rate of 412 ml/min was
assumed [4], resulting in an average flow velocity of 0.243 m/s. Since grafts exhibiting
flow rates less than 100 ml/min are considered failing, for the 1.2-mm thick NH model
this flow rate was used to calculate an average flow velocity of 0.164 m/s. From the
average flow velocities the laminar flow profiles were defined and implemented in the
COMSOL models.
The simulated heat transfer equation was the Pennes bioheat equation:
ρ · Cp
∂T
∂t
= ∇·k∇T + Q + Qperf
+A,
(2)
where r is mass density [kg/m
3], k is thermal conductivity [W/m·K], T is tempera-
ture [K], A is a metabolic heat generation term [W/m
3] (which was neglected because
it was small compared to acoustic power deposition Q [W/m
3]), Cp is specific heat
capacity [J/kg·K], and Qperf represents heat transfer loss due to perfusion [W/m
3].
Because the general heat transfer application in COMSOL does not include the ther-
mal effects of perfusion included in the Pennes bioheat equation, the effects of perfu-
sion were simulated in the muscle and fat tissues using
Qperf =( Tblood − T) × (1 − κ)
×ρblood × Cpblood × ωtissue,
(3)
where ω is the blood perfusion rate of the tissue [s
-1]a n d is a term to account for
the incomplete thermal transfer to perfused blood. In our simulations  was assumed
to be zero (also assumed by Pennes and most subsequent investigators [34]) to model
complete thermal equilibration between the blood and tissue.
Thermal damage to healthy native tissues, a major concern during hyperthermia, can
be reduced with active skin surface cooling [35,36]. The pre-exposure skin cooling was
simulated in COMSOL by solving a steady-state model prior to ultrasound exposure.
In this model, the skin boundary was held constant at 20°C and the blood entering the
graft and perfusing the tissue was held constant at 37°C. Using the skin-cooling model,
the temperatures resulting from 10-second or 30-second transient applications with
the ultrasound power deposition values from the FDTD simulations were calculated.
To explore the effects of intermittent ultrasound exposure, the temperatures during
the cool-down period following the ultrasound exposure were simulated.
Results
Simulated pressure and power depositions for the 1.5- and 3.2-MHz transducers
Our simulated pressure results showed that, while the focus was positioned at the rear
graft wall for both transducers, the focal zone of the 1.5-MHz transducer spanned the
width of the graft (Figure 2a) while the focal zone of the 3.2-MHz transducer covered
only the rear graft wall (Figure 2b). Reflection and absorption of the ultrasound beam
by the ePTFE graft can be seen in the reduction of the pressure magnitude behind the
rear ePTFE wall, at which location the magnitudes of the pressures from the 1.5- and
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5 N/m
2 and 1.2 × 10
5 N/m
2,
respectively.
The high acoustic attenuation of ePTFE caused approximately five times more power
to be deposited within the graft than the adjacent tissues (Figure 3). The maximum Q
for the 1.5-MHz transducer was 2.75 × 10
7 W/m
3 in the front graft wall (Figure 3a),
and for the 3.2-MHz transducer, almost 8 × 10
7 W/m
3 (Figure 3b) in the rear graft
wall.
Simulated temperature profiles
The temperatures in the center 2D slice in line with the length of the graft after 30
seconds of ultrasound exposure are shown in Figure 4. Tissue and graft temperatures
along the direction of ultrasound propagation through the center of the ultrasound
focus are plotted in Figure 5. Modelling of NH-free grafts showed that the 1.5-MHz
transducer caused more heating at the front graft wall (Figures 4a and 5a) while the
3.2-MHz transducer generated more heat at the rear graft wall (Figures 4c and 5c); the
maximal temperature reached in either of the graft wall locations was 45°C for both
transducers for the case of NH-free grafts. Heat convection due to blood flow acted as
a large heat sink. However, with hyperplasia the convective boundary was moved
Figure 2 Pressure magnitude in the central plane aligned with the graft length from the FDTD
model. (a) The focal zone of pressure produced by the 1.5-MHz transducer extends across the graft. In
contrast, (b) the focal zone of pressure produced by the 3.2-MHz transducer covers only the rear graft wall.
Intimal hyperplasia models are shown. Both transducers were focused on the rear graft wall.
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transducers caused graft-wall heating up to 50°C. Note that the 3.2-MHz transducer
heated less adjacent soft tissue than the 1.5-MHz transducer; the 40°C region extended
about twice as deep into the muscle tissue for the 1.5-MHz exposure (Figure 4b) com-
pared to the 3.2-MHz results (Figure 4d). Both transducer models predicted very little
heating in the blood, even with the reduction in volumetric flow from 412 ml/min (in
the absence of hyperplasia) to 100 ml/min (in the presence of hyperplasia).
Figure 6 shows the temperature profiles immediately after a 30-second ultrasound
exposure. Ten seconds after the exposure from the 1.5-MHz transducer had ceased,
the temperatures cooled to within 2 and 2.5°C of body temperature (37°C) for the
hyperplasia-free and hyperplastic grafts, respectively. During the same 10-second dura-
tion, grafts that were exposed to the 3.2-MHz transducer cooled faster and their tem-
peratures were within 1 and 2°C of body temperature for the hyperplasia-free and
hyperplasic grafts, respectively. Sixty seconds after the ultrasound exposure ceased,
graft temperatures had returned to the pre-exposure values under all conditions (i.e.,
for both frequencies and with or without hyperplasia).
Figure 3 Power deposition Q in the central plane aligned with the graft length from the FDTD
model. Q in the central plane aligned with the graft length was calculated for the (a) 1.5-MHz transducer
(0.6 W incident power) and (b) 3.2-MHz transducer (0.375 W incident power), focused on the back wall.
Intimal hyperplasia models are shown. With the 1.5-MHz transducer, the ePTFE absorbed more power at
the front wall, leaving less to be absorbed in the rear graft wall, while the 3.2-MHz transducer deposited
most of its power in the rear wall of the graft.
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30 seconds of ultrasound exposure. 0.6 W of acoustic power was applied to the 1.5-MHz models with
(a) no hyperplasia and (b) 1.2-mm of hyperplasia. 0.375 W was applied to the 3.2-MHz models with (c) no
hyperplasia and (d) 1.2-mm of hyperplasia. With hyperplasia, 50°C was reached within the graft material for
both transducers.
Figure 5 Temperatures along the direction of ultrasound propagation, through the center of the
ultrasound focal zone. Temperature along the direction of ultrasound propagation through the center of
the ultrasound focal zone after 0, 5, and 30 seconds of ultrasound exposure. The 1.5-MHz transducer
models are shown in (a) and (b). The 3.2-MHz transducer models are shown in (c) and (d). After 30
seconds, the simulations showed a temperature of approximately 50°C in the graft walls for models (b) and
(d) with 1.2-mm thick intimal hyperplasia.
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1.5- and 3.2-MHz transducer modelling
Wave frequency is an important parameter in therapeutic ultrasound. Ultrasound
attenuation increases with frequency; consequently, high-frequency ultrasound is used
for imaging and therapy near or at the body surface, while low-frequency ultrasound is
appropriate for deeper imaging and therapy [37,38]. Frequency also has an effect on
the dimensions of the focal zone. Higher frequency waves focus to smaller zones [21].
The increase in frequency from 1.5 MHz to 3.2 MHz, a factor of 2.1, causes the focal
length and width to decrease by this same factor for a given transducer geometry. In
addition, the difference in the ratio of transducer focal length to diameter for the 1.5-
and 3.2-MHz transducers, 1.8 and 1.4, respectively, further reduces the length of the
focal zone by a factor of 1.3. These differences are evident in Figure 2. The focal zone
for the 3.2-MHz transducer was small enough that power was deposited primarily in
the rear graft wall (Figure 3b).
The amount of ultrasound power absorbed by a material depends on, among other
things, the material’s acoustic attenuation (Equation 1). The attenuation of ePTFE is
almost 10 times greater than the tissues surrounding the ePTFE graft (Table 2). Conse-
quently, the ePTFE material absorbed much more power than native tissue from the
ultrasound beam. This strategic concentration of power created the high temperatures
within the graft and the mild heating in the surrounding tissues (Figures 4 and 5).
Figure 6 Post ultrasound-exposure cooling profiles. Post ultrasound-exposure cooling profiles.
Temperatures are along the direction of ultrasound propagation through the center of the ultrasound
focus at times 0, 10, 30 and 60 seconds after termination of exposure. The 1.5-MHz transducer models are
shown in (a) and (b). The 3.2-MHz transducer models are shown in (c) and (d). After 30 seconds,
temperatures cool to within 1°C of 37°C (body temperature).
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of the 3.2-MHz transducer caused a higher, more concentrated power deposition pat-
tern. Although the 3.2-MHz transducer operated at 63% of the power of the 1.5-MHz
transducer it deposited a maximum Q approximately three times more than the 1.5-
MHz transducer (Figures 3a and 3b). Interestingly, the 3.2-MHz transducer generated
similar temperatures while depositing a higher maximum Q with less overall power
than the 1.5-MHz transducer. The roughly three-fold Q of the 3.2-MHz transducer
induced a faster but more localized increase in temperature than the 1.5-MHz transdu-
cer. As a result, the more localized heating produced larger spatial temperature gradi-
ents. These large gradients gave rise to greater heat transfer away from the focal region
of the 3.2-MHz transducer, limiting graft and tissue temperatures to be similar to
those in the 1.5-MHz transducer model after 30 seconds of exposure.
Temperature modelling
Understanding cellular response to specific temperatures provides relevance for the
thermal modelling. While cellular response to thermal exposure varies with cell species
and origin [39], both apoptosis (organized cell death) and necrosis (ruptured cellular
membrane) can occur in response to thermal exposure. In general, temperatures below
43°C can cause a heat-shock-protein response but only induce apoptosis mildly [40,41].
Samali et al. [42] and Harmon et al. [43] exposed suspended cells for one hour and for
30 minutes, respectively, and concluded the turning point from apoptosis to necrosis
occurred at 45°C. Apoptosis, rather than necrosis, is the preferred cell death pathway for
our target clinical application. Necrotic death causes inflammation and the attraction of
macrophages that may exacerbate NH formation. Hehrlein et al. reported that vascular
damage from high-temperature exposure led to increased intimal growth in canines
[44]. In addition, temperatures exceeding 47°C cause epidermal and dermal injury [45].
Taken together, the target graft temperature should be between 45-47°C to induce apop-
totic death while limiting necrotic death.
Differences in thermal exposure between the 1.5- and 3.2-MHz transducer simula-
tions may influence the extent of cell death on implanted ePTFE grafts. For example,
the 3.2-MHz transducer heated the graft to a higher temperature after 5 seconds
(Figures 5b and 5d). Consequently, using the 3.2-MHz transducer the luminal graft
surface may reach effective elevated temperatures more quickly, thereby heating hyper-
plasia at effective temperatures for a greater portion of the 30 second ultrasound pulse.
The 3.2-MHz transducer modelling also showed less native tissue heating above 43°C.
As a result, the 3.2-MHz transducer’s more confined spatial heating may facilitate ther-
mal exposure at the anastomosis site with less damage to adjacent tissues, which is a
major advantage when compared to the 1.5-MHz transducer.
Our modelling results suggest that the ultrasound should be delivered in an intermit-
tent manner in our target clinical application. Non-continuous ultrasound therapy
helps to reduce unwanted heating of healthy tissues by allowing cooling between the
ultrasound pulses. Pulsed ultrasound exposure could also help ensure that hyperplasia
receives only mild heat, thereby avoiding tissue necrosis. To avoid residual temperature
buildup during pulsed ultrasound exposure, a 30-second exposure should be followed
b ya3 0 - s e c o n dr e s t ,f o rad u t yc y c l eo f0 . 5 .Shorter rest times would not allow suffi-
c i e n tt i m ef o rt h et i s s u et or e t u r nt o3 7 ° Cb efore the next ultrasound pulse exposed
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take twice as long, lasting up to an hour.
During the ultrasound exposure the low thermal conductivity of the tissue slowed
thermal diffusion into the tissue. Thus, after 30 seconds of exposure, the rise in tem-
perature was confined to and in close proximity of the ePTFE material (Figure 5).
Furthermore, the heat that did transfer into the tissue also dissipated slowly during the
cooling cycle, evident by the regions in the fat and muscle which cooled to the pre-
exposure temperatures last (Figure 6). Consequently, in our target clinical application
the cooling time between consecutive ultrasound pulses, which limited by the thermal
conductivity of the tissue, is necessary in order to avoid thermal buildup.
D u et oc o n v e c t i o n ,t h eb l o o d - e P T F Eb o u n d a r y( F i g u r e s5 aa n d5 c )a n dt h eb l o o d -
NH boundary (Figures 5b and 5d) did not reach temperatures capable of inducing
apoptotic cell death, suggesting ultrasound heating may not prevent NH formation in
NH-free grafts and may not be able to treat pre-existent NH entirely, respectively.
Attempts to heat more of the NH region using longer ultrasound exposures could
cause thermal damage to tissue adjacent to the graft where the heat dissipated more
slowly. However, temperatures capable of inducing apoptosis were generated near the
NH-ePTFE boundary (Figures 5b and 5d). As a result, repeated ultrasound exposure
may reduce NH growth and delay the development of significant stenosis. In the pre-
sence of NH, a graft can still remain functional as long as the NH size is not so big
that it impedes blood flow. Therefore, even though the proposed approach may not
completely prevent the formation of NH or remove a pre-existing NH entirely,
repeated ultrasound exposure may restrict the NH size, thereby lengthening the
patency rate of the graft.
Conclusions
Results of our modelling showed selective ePTFE graft heating could be achieved by
either the 1.5-MHz or the 3.2-MHz transducer. Both transducers can lead to tempera-
tures capable of inducing apoptosis near the NH-ePTFE boundary. The temperature
increase in blood was negligible using either transducer, while the temperature increase
in the adjacent soft tissue was smaller when the 3.2-MHz transducer was used. Tissue
temperature variations due to the presence or absence of NH suggest the need of
patient-specific ultrasound exposure protocols. Overall, intermittent ultrasound heating
may have the potential for clinical application to reduce neointimal hyperplasia and
failure of ePTFE vascular grafts.
Appendix A
Detailed FDTD method
Acoustic waves can be described [46] using Newton’s force equation (A1) and the con-
servation of mass (A2):
∂¯ u
∂t
=
∇p
ρo
+
ξ
ρo
∇2¯ u (A1)
∂p
∂t
= −
1
K
∇·¯ u, (A2)
where
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ux, uy, and uz are the respective particle velocities in the ẋ, ẏ, and ż directions,
p is the pressure,
ξ =

η +
4
3
η’

,
h is the dynamic coefficient of shear viscosity of the material,
h’ is the dynamic coefficient of bulk viscosity of the material,
ro is the average mass density of the material, and
Κ is the compressibility of the material.
Considering compression waves only (shear waves attenuate rapidly with distance
[46]), these two equations can be solved in 3D using an FDTD method. Solving for
pressure p in finite-difference form, (A2) yields
pn+1
ijk = −
 t
Kijk
	
un
xi+1jk − un
xijk
 x
+
un
yij+1k − un
yijk
 y
+
un
zijk+1 − un
zijk
 z


+ pn
ijk.
(A3)
Here Δx, Δy,a n dΔz are the lengths of the voxels in the computational grid space,
the letters i, j, and k denote the x, y and z indices, respectively (see Figure 7), and Δt is
the increment of time between steps. For convergence, Δt is limited by the Courant
condition [24]. The superscript n denotes the current time step, and n+1 represents
the next time step. The ux component of the velocity from (A1) is given in finite-dif-
ference form in (A4). The uy and uz solutions (not shown) are similarly defined.
un+1
xijk =
− t
ρ 
ijk x

pn
ijk − pn
i−1jk

+ un
xijk +
 t
ρ 
ijk x2

ξijkux
n
xi+1jk
+ξi−1jkun
xi−1jk −

ξijk + ξi−1jk

· un
xijk.
(A4)
Figure 7 FDTD grid space to solve Equations (A1) and (A2). FDTD grid space to solve Equations (A1)
and (A2). This figure shows pressure and velocity in two dimensions only. The third dimension, z, is
perpendicular to the x-y plane.
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Page 13 of 15Because the velocity u is defined on the boundaries of each voxel, the material den-
sity r’ also must be defined on the edges. As a result, r’ is approximated as the average
density of two adjacent cells:
ρ ijk =

ρn
i−1jk + ρn
ijk

2. (A5)
The FDTD algorithm works iteratively between (A3) and (A4), as well as between the
respective equations for the uy and uz velocity solutions not shown here, to calculate
the pressure and velocities at each time step throughout the entire model grid space.
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